SK64399A3 - Multivalent salts of pyridostigmine and related compounds - Google Patents
Multivalent salts of pyridostigmine and related compounds Download PDFInfo
- Publication number
- SK64399A3 SK64399A3 SK643-99A SK64399A SK64399A3 SK 64399 A3 SK64399 A3 SK 64399A3 SK 64399 A SK64399 A SK 64399A SK 64399 A3 SK64399 A3 SK 64399A3
- Authority
- SK
- Slovakia
- Prior art keywords
- anion
- compound
- compound according
- anions
- patient
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
- C07C271/42—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3118696P | 1996-11-19 | 1996-11-19 | |
| PCT/US1997/020509 WO1998022458A1 (en) | 1996-11-19 | 1997-11-10 | Multivalent salts of pyridostigmine and related compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK64399A3 true SK64399A3 (en) | 2000-05-16 |
Family
ID=21858083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK643-99A SK64399A3 (en) | 1996-11-19 | 1997-11-10 | Multivalent salts of pyridostigmine and related compounds |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6211201B1 (ko) |
| EP (1) | EP0941224A4 (ko) |
| JP (1) | JP2001505561A (ko) |
| KR (1) | KR20000069028A (ko) |
| CN (1) | CN1237969A (ko) |
| AU (1) | AU717740B2 (ko) |
| BR (1) | BR9713112A (ko) |
| CA (1) | CA2271786A1 (ko) |
| CZ (1) | CZ172799A3 (ko) |
| HU (1) | HUP9904040A3 (ko) |
| IL (1) | IL129619A0 (ko) |
| NO (1) | NO992384L (ko) |
| NZ (1) | NZ335419A (ko) |
| PL (1) | PL333414A1 (ko) |
| SI (1) | SI20018A (ko) |
| SK (1) | SK64399A3 (ko) |
| WO (1) | WO1998022458A1 (ko) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1390032A4 (en) * | 2001-05-11 | 2004-12-29 | Marvin B Bacaner | NOVEL QUATERNARY AMMONIUM COMPOSITIONS COUPLED WITH AUXILIARY ANIONS, USES THEREOF IN KITS AND THE USE THEREOF FOR PREVENTING AND TREATING CERTAIN CONDITIONS |
| EP1558591B1 (en) | 2002-10-07 | 2014-05-07 | The Regents of The University of California | Modulation of anxiety through blockade of anandamide hydrolysis |
| US20050182252A1 (en) | 2004-02-13 | 2005-08-18 | Reddy K. R. | Novel 2'-C-methyl nucleoside derivatives |
| EP3105238A4 (en) | 2014-02-13 | 2017-11-08 | Ligand Pharmaceuticals, Inc. | Prodrug compounds and their uses |
| WO2016003812A1 (en) | 2014-07-02 | 2016-01-07 | Ligand Pharmaceuticals, Inc. | Prodrug compounds and uses therof |
| CN107854428A (zh) * | 2016-12-20 | 2018-03-30 | 成都医学院 | 一种溴吡斯的明糖浆剂及其制备方法 |
| CN111788196A (zh) | 2018-01-09 | 2020-10-16 | 配体药物公司 | 缩醛化合物及其治疗用途 |
| CN113277961B (zh) * | 2021-04-09 | 2023-05-09 | 深圳市新浩瑞医药科技有限公司 | 一种溴新斯的明的合成方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4692530A (en) * | 1967-03-07 | 1987-09-08 | The United States Of America As Represented By The Secretary Of The Army | Chemical agents |
| US4686293A (en) * | 1967-05-29 | 1987-08-11 | The United States Of America As Represented By The Secretary Of The Army | Chemical agents |
| US4672120A (en) * | 1967-07-03 | 1987-06-09 | The United States Of America As Represented By The Secretary Of The Army | Chemical agents |
| US4246416A (en) * | 1967-12-01 | 1981-01-20 | The United States Of America As Represented By The Secretary Of The Army | Chemical agents |
| US4677222A (en) * | 1968-01-22 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Army | Ketobenzylcarbamates |
| US5534623A (en) * | 1993-01-21 | 1996-07-09 | Du Pont (Uk) Limited | Process for preparing a polyunsaturated diazonium compounds |
-
1997
- 1997-11-10 AU AU62367/98A patent/AU717740B2/en not_active Ceased
- 1997-11-10 US US09/308,723 patent/US6211201B1/en not_active Expired - Lifetime
- 1997-11-10 NZ NZ335419A patent/NZ335419A/xx not_active IP Right Cessation
- 1997-11-10 SI SI9720075A patent/SI20018A/sl not_active IP Right Cessation
- 1997-11-10 BR BR9713112-1A patent/BR9713112A/pt not_active IP Right Cessation
- 1997-11-10 SK SK643-99A patent/SK64399A3/sk unknown
- 1997-11-10 EP EP97954835A patent/EP0941224A4/en not_active Withdrawn
- 1997-11-10 KR KR1019997004410A patent/KR20000069028A/ko not_active Application Discontinuation
- 1997-11-10 IL IL12961997A patent/IL129619A0/xx unknown
- 1997-11-10 CA CA002271786A patent/CA2271786A1/en not_active Abandoned
- 1997-11-10 PL PL97333414A patent/PL333414A1/xx unknown
- 1997-11-10 WO PCT/US1997/020509 patent/WO1998022458A1/en not_active Application Discontinuation
- 1997-11-10 HU HU9904040A patent/HUP9904040A3/hu unknown
- 1997-11-10 CZ CZ991727A patent/CZ172799A3/cs unknown
- 1997-11-10 JP JP52371598A patent/JP2001505561A/ja active Pending
- 1997-11-10 CN CN97199841A patent/CN1237969A/zh active Pending
-
1999
- 1999-05-18 NO NO992384A patent/NO992384L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO992384L (no) | 1999-07-16 |
| SI20018A (sl) | 2000-02-29 |
| IL129619A0 (en) | 2000-02-29 |
| HUP9904040A2 (hu) | 2000-05-28 |
| WO1998022458A1 (en) | 1998-05-28 |
| PL333414A1 (en) | 1999-12-06 |
| EP0941224A1 (en) | 1999-09-15 |
| JP2001505561A (ja) | 2001-04-24 |
| CZ172799A3 (cs) | 1999-10-13 |
| AU717740B2 (en) | 2000-03-30 |
| US6211201B1 (en) | 2001-04-03 |
| KR20000069028A (ko) | 2000-11-25 |
| CN1237969A (zh) | 1999-12-08 |
| BR9713112A (pt) | 2000-04-11 |
| AU6236798A (en) | 1998-06-10 |
| NO992384D0 (no) | 1999-05-18 |
| NZ335419A (en) | 2000-05-26 |
| HUP9904040A3 (en) | 2000-09-28 |
| CA2271786A1 (en) | 1998-05-28 |
| EP0941224A4 (en) | 2000-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU703340B2 (en) | Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagnosis | |
| DE60011446T2 (de) | Substituierte Pyridinopentaazamakrocyclokomplexe mit Superoxiddismutaseaktivität | |
| KR920021512A (ko) | 신규의 디알킬렌피페리디노 화합물 및 이의 거울상 이성질체 이의 제조방법 및 이를 함유하는 약제학적 조성물 | |
| US4645661A (en) | Method for alleviating cisplatin-induced nephrotoxicity and dithiocarbamate compounds for effecting same | |
| JP6267638B2 (ja) | 疾患の治療方法 | |
| JPS6146455B2 (ko) | ||
| SK64399A3 (en) | Multivalent salts of pyridostigmine and related compounds | |
| US11752135B2 (en) | Liquid pharmaceutical formulation | |
| US20040063681A1 (en) | Methods for using gold (III) complexes as anti-tumor and anti-HIV agents | |
| US4544759A (en) | Platinum complexes of antitumor agents | |
| US3962447A (en) | Novel pro-drug derivatives of pyridinium aldoxime type cholinesterase reactivators and method of using same | |
| RU96119798A (ru) | Трехъядерные катионные комплексы платины, обладающие противоопухолевой активностью, и фармацевтические композиции, содержащие эти комплексы | |
| NL8400722A (nl) | Farmaceutische preparaten met een antineoplastische activiteit. | |
| US20070043070A1 (en) | Weak base salts | |
| US5118698A (en) | Pharmaceutical preparations | |
| JPH10509159A (ja) | 抗腫瘍活性を有する三核性カチオン性プラチナ錯体、及びそれらを含有する医薬組成物 | |
| MXPA99004608A (en) | Multivalent salts of pyridostigmine and related compounds | |
| US3432603A (en) | Process for weight reduction | |
| US4505925A (en) | N,N-diethyl-5-methyl-2H-1-benzothiopyrano-4,3,2-cd-indazole-2-ethanamine compositions and methods for their use | |
| JP7159177B2 (ja) | ３’デアミノ－３’－（２”－ピロリン－１”－イル）－５－イミノ－１３－デオキシアントラサイクリンおよび調製方法 | |
| MXPA04009201A (es) | Solubilizacion de bases debiles. | |
| WO1995020956A1 (en) | Anti-tumour medical preparation on the basis of carboplatin and the method of its production | |
| JPS6153267A (ja) | 酸化および湿気に抵抗性のプロカテロ−ル誘導体およびその製法 | |
| ZA200107313B (en) | Water soluble transplatinum complexes with anti-cancer activity and method of using same. | |
| WO2021252874A1 (en) | Xpo1 inhibitors for use in treating cancer |